Stem cell therapy for voiding and erectile dysfunction

Nature Reviews Urology

Volumn 9, Issue 8, 2012, Pages 435-447

  Vaegler, Martin ^a   Lenis, Andrew T ^b   Daum, Lisa ^a   Amend, Bastian ^a   Stenzl, Arnulf ^a   Toomey, Patricia ^a   Renninger, Markus ^a   Damaser, Margot S ^b   Sievert, Karl Dietrich ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; BLADDER WALL; DISEASE COURSE; ERECTILE DYSFUNCTION; FIBROSIS; HUMAN; INFLAMMATION; MICTURITION DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; URETHRA; FEMALE; MALE; MULTIPOTENT STEM CELL; TRANSPLANTATION; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, STRESS;

ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; MULTIPOTENT STEM CELLS; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, STRESS;

EID: 84864869226     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.111     Document Type: Review

References (102)

1. Milsom, I. Lower urinary tract symptoms in women. Curr. Opin. Urol. 19, 337-341 (2009).
2. Defade, B. P., Carson, C. C. 3rd & Kennelly, M. J. Postprostatectomy erectile dysfunction: the role of penile rehabilitation. Rev. Urol. 13, 6-13 (2011).
3. Stothers, L. & Friedman, B. Risk factors for the development of stress urinary incontinence in women. Curr. Urol. Rep. 12, 363-369 (2011).
4. Sievert, K. D. et al. Can we prevent incontinence?: ICI-RS 2011. Neurourol. Urodyn. 31, 390-399 (2012).
5. Richter, H. E. et al. Retropubic versus transobturator midurethral slings for stress incontinence. N. Engl. J. Med. 362, 2066-2076 (2010).
6. Sadeghi-Nejad, H. Penile prosthesis surgery: a review of prosthetic devices and associated complications. J. Sex. Med. 4, 296-309 (2007). (Pubitemid 46394703)
7. Bongso, A., Fong, C. Y. & Gauthaman, K. Taking stem cells to the clinic: major challenges. J. Cell Biochem. 105, 1352-1360 (2008).
8. Choumerianou, D. M., Dimitriou, H. & Kalmanti, M. Stem cells: promises versus limitations. Tissue Eng. Part B Rev. 14, 53-60 (2008).
9. Kolf, C. M., Cho, E. & Tuan, R. S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 9, 204 (2007).
10. Chamberlain, G., Fox, J., Ashton, B. & Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739-2749 (2007). (Pubitemid 350127858)
11. Furuta, A., Carr, L. K., Yoshimura, N. & Chancellor, M. B. Advances in the understanding of stress urinary incontinence and the promise of stem-cell therapy. Rev. Urol. 9, 106-112 (2007).
12. Sakaguchi, Y., Sekiya, I., Yagishita, K. & Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52, 2521-2529 (2005). (Pubitemid 41117441)
13. Usas, A. & Huard, J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401-5406 (2007). (Pubitemid 47599647)
14. Ye, L., Haider, H. & Sim, E. K. Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp. Biol. Med. (Maywood) 231, 8-19 (2006). (Pubitemid 43063973)
15. Klein, J. D. & Fauza, D. O. Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol. Biol. 698, 75-88 (2011).
16. Borlongan, C. V. et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev. 19, 439-452 (2010).
17. Baksh, D., Yao, R. & Tuan, R. S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25, 1384-1392 (2007). (Pubitemid 47106005)
18. Zhang, Y. et al. Urine derived cells are a potential source for urological tissue reconstruction. J. Urol. 180, 2226-2233 (2008).
19. Drewa, T., Joachimiak, R., Kaznica, A., Sarafian, V. & Pokrywczynska, M. Hair stem cells for bladder regeneration in rats: preliminary results. Transplant. Proc. 41, 4345-4351 (2009).
20. Bailey, A. M., Kapur, S. & Katz, A. J. Characterization of adipose-derived stem cells: an update. Curr. Stem Cell Res. Ther. 5, 95-102 (2010).
21. Kucia, M. J. et al. Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. Stem Cells 26, 2083-2092 (2008).
22. Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313 (2008).
23. Amos, P. J. et al. Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells. Am. J. Physiol. Cell Physiol. 301, 1378-1388 (2011).
24. Estes, B. T., Wu, A. W. & Guilak, F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 54, 1222-1232 (2006). (Pubitemid 43672934)
25. Panepucci, R. A. et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22, 1263-1278 (2004). (Pubitemid 39646504)
26. Silva, W. A. Jr et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21, 661-666 (2003).
27. Wang, H. J., Chuang, Y. C. & Chancellor, M. B. Development of cellular therapy for the treatment of stress urinary incontinence. Int. Urogynecol. J. 22, 1075-1083 (2011).
28. Baxter, M. A. et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22, 675-682 (2004). (Pubitemid 39172200)
29. Vacanti, V. et al. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J. Cell Physiol. 205, 194-201 (2005). (Pubitemid 41428901)
30. Aggarwal, S. & Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822 (2005). (Pubitemid 40223708)
31. Klyushnenkova, E. et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12, 47-57 (2005). (Pubitemid 40576763)
32. Patel, S. A. & Rameshwar, P. Stem cell transplantation for hematological malignancies: prospects for personalized medicine and co-therapy with mesenchymal stem cells. Curr. Pharmacogenomics Person. Med. 9, 229-239 (2011).
33. Bahk, J. Y., Jung, J. H., Han, H., Min, S. K. & Lee, Y. S. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp. Clin. Transplant. 8, 150-160 (2010).
34. Hare, J. M. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286 (2009).
35. Vieira, N. M. et al. Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice. Stem Cell Rev. 6, 560-566 (2010).
36. Horwitz, E. M. et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99, 8932-8937 (2002). (Pubitemid 34693661)
37. Le Blanc, K. et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79, 1607-1614 (2005). (Pubitemid 40847594)
38. Roufosse, C. A., Direkze, N. C., Otto, W. R. & Wright, N. A. Circulating mesenchymal stem cells. Int. J. Biochem. Cell Biol. 36, 585-597 (2004). (Pubitemid 38316816)
39. Sundararaman, S. et al. Plasmid-based transient human stromal cell-derived factor1 gene transfer improves cardiac function in chronic heart failure. Gene Ther. 18, 867-873 (2011).
40. Woo, L. L. et al. Simulated childbirth injuries in an inbred rat strain. Neurourol. Urodyn. 28, 356-361 (2009).
41. Wood, H. M. et al. Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats. J. Urol. 180, 753-759 (2008).
42. Vricella, G. J. et al. Expression of monocyte chemotactic protein 3 following simulated birth trauma in a murine model of obesity. Urology 76, 1512-1517 (2010).
43. Cruz, M. et al. Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats. Obstet. Gynecol. Int. 2012, 612946 (2012).
44. Lin, G. et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 12, 88-95 (2010).
45. Dissaranan, C. et al. Intravenous mesenchymal stem cells home to the urethra and facilitate recovery from stress urinary incontinence after childbirth injury via local secretion of paracrine factors. J. Urol. 185, 73 (2011).
46. Lin, G. et al. Tracking intracavernously injected adipose-derived stem cells to bone marrow. Int. J. Impot. Res. 23, 268-275 (2011).
47. Penn, M. S. Importance of the SDF1:CXCR4 axis in myocardial repair. Circ. Res. 104, 1133-1135 (2009).
48. Hammerick, K. E., Longaker, M. T. & Prinz, F. B. In vitro effects of direct current electric fields on adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 397, 12-17 (2010).
49. Li, L. et al. Direct-current electrical field guides neuronal stem/progenitor cell migration. Stem Cells 26, 2193-2200 (2008).
50. Zhang, J. et al. Electrically guiding migration of human induced pluripotent stem cells. Stem Cell Rev. 7, 987-996 (2011).
51. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006). (Pubitemid 44269669)
52. Drost, A. C. et al. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann. NY Acad. Sci. 1176, 135-143 (2009).
53. Fu, Q., Song, X. F., Liao, G. L., Deng, C. L. & Cui, L. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology 75, 718-723 (2010).
54. Anumanthan, G. et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J. Urol. 180, 1778-1783 (2008).
55. Tian, H. et al. Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng. Part A 16, 1769-1779 (2010).
56. Staack, A., Hayward, S. W., Baskin, L. S. & Cunha, G. R. Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration. Differentiation 73, 121-133 (2005). (Pubitemid 41632501)
57. Caplan, A. I. & Correa, D. The MSC: an injury drugstore. Cell Stem Cell 9, 11-15 (2011).
58. Meirelles Lda, S., Fontes, A. M., Covas, D. T. & Caplan, A. I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419-427 (2009).
59. da Silva Meirelles, L., Caplan, A. I. & Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287-2299 (2008).
60. Shabbir, A., Zisa, D., Suzuki, G. & Lee, T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 296, 1888-1897 (2009).
61. Carr, L. K. et al. 1year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 881-883 (2008). (Pubitemid 351597572)
62. Carr, L. et al. Autologous muscle-derived cells as therapy for stress urinary incontinence: a randomized, dose-ranging trial. J. Urol. 183, 587-588 (2010).
63. Peters, K. et al. Autologous muscle-derived cell therapy for the treatment of stress urinary incontinence: a multi-center experience. J. Urol. 185, 535-536 (2011).
64. Gill, B. C., Moore, C. & Damaser, M. S. Postpartum stress urinary incontinence: lessons from animal models. Expert Rev. Obstet. Gynecol. 5, 567-580 (2010).
65. Jiang, H. H. & Damaser, M. S. Animal models of stress urinary incontinence. Handb. Exp. Pharmacol. 202, 45-67 (2011).
66. Sajadi, K. P., Gill, B. C. & Damaser, M. S. Neurogenic aspects of stress urinary incontinence. Curr. Opin. Obstet. Gynecol. 22, 425-429 (2010).
67. Sievert, K. D. et al. The effect of simulated birth trauma and/or ovariectomy on rodent continence mechanism. Part I: functional and structural change. J. Urol. 166, 311-317 (2001).
68. Kinebuchi, Y. et al. Autologous bonemarrowderived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int. J. Urol. 17, 359-368 (2010).
69. Kwon, D. et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 68, 449-454 (2006). (Pubitemid 44175517)
70. Corcos, J. et al. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol. Urodyn. 30, 447-455 (2011).
71. Zhao, W. et al. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur. Urol. 59, 155-163 (2011).
72. Nishijima, S. et al. Restoration of bladder contraction by bone marrow transplantation in rats with underactive bladder. Biomed. Res. 28, 275-280 (2007). (Pubitemid 350268140)
73. Huang, Y. C. et al. Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J. Urol. 183, 1232-1240 (2010).
74. Woo, L. L. et al. Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data. J. Urol. 185, 1132-1138 (2011).
75. Huang, Y. C. et al. The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J. Sex. Med. 7, 1391-1400 (2010).
76. Albersen, M. et al. Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J. Sex. Med. 7, 3331-3340 (2010).
77. Bivalacqua, T. J. et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 292, 1278-1290 (2007).
78. Qiu, X. et al. Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J. Androl. 33, 37-44 (2012).
79. Jaski, B. E. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a firstinhuman phase 1/2 clinical trial. J. Card. Fail. 15, 171-181 (2009).
80. Atala, A. Tissue engineering of human bladder. Br. Med. Bull. 97, 81-104 (2011).
81. Zou, X. H. et al. Mesenchymal stem cell seeded knitted silk sling for the treatment of stress urinary incontinence. Biomaterials 31, 4872-4879 (2010).
82. Feil, G., Maurer, S., Nagele, U., Sievert, K. D. & Stenzl, A. Bioartificial urothelium generated from bladder washings. A future therapeutic option for reconstructive surgery. Urologe A 47, 1091-1096 (2008).
83. Nagele, U. et al. In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings. Eur. Urol. 54, 1414-1422 (2008).
84. Sievert, K. D. et al. Introducing a large animal model to create urethral stricture similar to human stricture disease: a comparative experimental microscopic study. J. Urol. 187, 1101-1109 (2012).
85. Selim, M., Bullock, A. J., Blackwood, K. A., Chapple, C. R. & MacNeil, S. Developing biodegradable scaffolds for tissue engineering of the urethra. BJU Int. 107, 296-302 (2011).
86. Lai, J. Y., Yoon, C. Y., Yoo, J. J., Wulf, T. & Atala, A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J. Urol. 168, 1853-1858 (2002). (Pubitemid 35034105)
87. Atala, A., Bauer, S. B., Soker, S., Yoo, J. J. & Retik, A. B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241-1246 (2006).
88. Subramaniam, R., Hinley, J., Stahlschmidt, J. & Southgate, J. Tissue engineering potential of urothelial cells from diseased bladders. J. Urol. 186, 2014-2020 (2011).
89. Feil, G. et al. Investigations of urothelial cells seeded on commercially available small intestine submucosa. Eur. Urol. 50, 1330-1337 (2006). (Pubitemid 44692922)
90. Chung, S. Y. et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J. Urol. 174, 353-359 (2005). (Pubitemid 40825757)
91. Sharma, A. K. et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. Stem Cells 29, 241-250 (2011).
92. Sharma, A. K. et al. Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1, 8octanediolco-citrate) based thin films. Biomaterials 31, 6207-6217 (2010).
93. Tian, H. et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials 31, 870-877 (2010).
94. Jack, G. S. et al. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 30, 3259-3270 (2009).
95. Dorin, R. P., Pohl, H. G., De Filippo, R. E., Yoo, J. J. & Atala, A. Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J. Urol. 26, 323-326 (2008).
96. De Filippo, R. E., Yoo, J. J. & Atala, A. Urethral replacement using cell seeded tubularized collagen matrices. J. Urol. 168, 1789-1792 (2002). (Pubitemid 35034086)
97. Nuininga, J. E. et al. Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen biomatrices: key issues in growth factor addition. Tissue Eng. Part A 16, 3319-3328 (2010).
98. Raya-Rivera, A. et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 377, 1175-1182 (2011).
99. Sievert, K. D. The next step in urethral reconstruction. Lancet 377, 1130-1131 (2011).
100. Raivich, G. & Makwana, M. The making of successful axonal regeneration: genes, molecules and signal transduction pathways. Brain Res. Rev. 53, 287-311 (2007). (Pubitemid 46177235)
101. Buckley, G., Metcalfe, A. D. & Ferguson, M. W. Peripheral nerve regeneration in the MRL/MpJ ear wound model. J. Anat. 218, 163-172 (2011).
102. May, F. et al. GDNF-transduced Schwann cell grafts enhance regeneration of erectile nerves. Eur. Urol. 54, 1179-1187 (2008).